Effects of a Potential Probiotic Strain Lactobacillus gasseri ATCC 33323 on Helicobacter pylori-Induced Inflammatory Response and Gene Expression in Coinfected Gastric Epithelial Cells
- 2020-11-18
- Probiotics and Antimicrobial Proteins 13(3)
- M. Yarmohammadi
- A. Yadegar
- M. Ebrahimi
- M. Zali
- PubMed: 33206342
- DOI: 10.1007/s12602-020-09721-z
Abstract
In the present study, we aimed to investigate the modulatory effects of a potential probiotic bacterium Lactobacillus gasseri ATCC 33323 on Helicobacter pylori-induced inflammatory response and gene expression in human gastric adenocarcinoma (AGS) cell line. The gastric epithelial cells were coinfected with a collection of H. pylori clinical strains alone or in combination with L. gasseri at a multiplicity of infection (MOI) of 1:100 for each bacterium, and incubated for different time points of 3, 6, and 12 h. IL-8 secretion from coinfected AGS cells after incubation at each time point was measured by an enzyme-linked immunosorbent assay (ELISA). The mRNA expression of IL-8, Bcl-2, β-catenin, integrin α5, and integrin β1 genes was determined by quantitative RT-PCR amplification of total RNA extracted from coinfected epithelial cells. L. gasseri significantly (P < 0.05 and P < 0.01) decreased the production of IL-8 in AGS cells coinfected with H. pylori strains at 6 h post-infection. We also detected that L. gasseri significantly (P < 0.05) down-regulated the gene expression level of IL-8 in H. pylori-stimulated AGS cells after 6 and 12 h of coinfection. Similarly, L. gasseri caused a significant decrease (P < 0.05) in mRNA expression of Bcl-2, β-catenin, integrin α5, and integrin β1 genes in AGS cells at 3 and 6 h after infection with H. pylori strains as compared with non-infected control cells. In conclusion, our results demonstrated that L. gasseri ameliorates H. pylori-induced inflammation and could be developed as a supplementation to the current treatment regimens administrated against H. pylori infection.
Keywords: Coinfection; Helicobacter pylori; IL-8; Inflammation; Lactobacillus gasseri ATCC 33323; Probiotic.
Research Insights
Supplement | Health Outcome | Effect Type | Effect Size |
---|---|---|---|
Lactobacillus gasseri | Reduced Inflammation Levels | Beneficial | Moderate |
Lactobacillus gasseri | Reduced Pro-inflammatory Gene Expression | Beneficial | Moderate |
Lactobacillus gasseri BNR17 | Reduced Inflammation | Beneficial | Moderate |
Lactobacillus gasseri KS-13 | Reduced Expression of Inflammation-Related Genes | Beneficial | Moderate |
Lactobacillus gasseri KS-13 | Reduced Gene Expression | Beneficial | Moderate |
Lactobacillus gasseri KS-13 | Reduced Inflammatory Response | Beneficial | Moderate |
Lactobacillus gasseri LAC-343 | Reduced IL-8 Gene Expression | Beneficial | Moderate |
Lactobacillus gasseri LAC-343 | Reduced IL-8 Production | Beneficial | Moderate |
Lactobacillus gasseri LBV 150N | Reduced Inflammatory Gene Expression in Helicobacter pylori-Stimulated Cells | Beneficial | Moderate |
Lactobacillus gasseri LBV 150N | Reduced Inflammatory Response to Helicobacter pylori | Beneficial | Moderate |
Lactobacillus gasseri LQ-36 | Reduced IL-8 Production in Gastric Epithelial Cells | Beneficial | Moderate |
Lactobacillus gasseri LQ-36 | Reduced Pro-inflammatory Gene Expression | Beneficial | Moderate |
Lactobacillus gasseri SD-5585 | Decreased Integrin β1 mRNA Expression | Beneficial | Moderate |
Lactobacillus gasseri SD-5585 | Reduced IL-8 Gene Expression | Beneficial | Moderate |
Lactobacillus gasseri SD-5585 | Reduced IL-8 Production | Beneficial | Moderate |
Lactobacillus gasseri SD-5585 | Reduced mRNA Expression of Bcl-2 | Beneficial | Moderate |
Lactobacillus gasseri SD-5585 | Reduced mRNA Expression of Integrin α5 | Beneficial | Moderate |
Lactobacillus gasseri SD-5585 | Reduced mRNA Expression of β-catenin | Beneficial | Moderate |
Lactobacillus gasseri UALg-05 | Reduced Expression of Inflammation-Related Genes | Beneficial | Moderate |
Lactobacillus gasseri UALg-05 | Reduced Inflammation Levels | Beneficial | Moderate |